Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CENPQ mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CENPQ mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CENPQ mRNA | CTD | PMID:30723492 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CENPQ mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | CENPQ (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CENPQ mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cenpq (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CENPQ mRNA | CTD | PMID:21570461 | 4-hydroxyphenyl retinamide | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Fenretinide results in increased expression of CENPQ mRNA | CTD | PMID:28973697 | 5-fluorouracil | affects response to substance | ISO | CENPQ (Homo sapiens) | 6480464 | CENPQ protein affects the susceptibility to Fluorouracil | CTD | PMID:15331170 | 5-fluorouracil | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of CENPQ mRNA | CTD | PMID:15331170 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CENPQ mRNA | CTD | PMID:24780913 and PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CENPQ mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of CENPQ mRNA | CTD | PMID:28959563 | aflatoxin B1 | affects expression | ISO | CENPQ (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CENPQ protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | CENPQ (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CENPQ gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of CENPQ mRNA | CTD | PMID:19770486 | aflatoxin M1 | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of CENPQ mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CENPQ mRNA | CTD | PMID:21934132 and PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of CENPQ mRNA | CTD | PMID:30047161 | benzo[a]pyrene | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CENPQ mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CENPQ mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | CENPQ (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CENPQ promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | bisphenol A results in increased expression of CENPQ mRNA | CTD | PMID:33221593 | calcitriol | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CENPQ mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CENPQ mRNA | CTD | PMID:21592394 | carbon nanotube | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of CENPQ mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of CENPQ mRNA | CTD | PMID:25620056 | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of CENPQ mRNA | CTD | PMID:18500788 | chlorpyrifos | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CENPQ mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CENPQ mRNA | CTD | PMID:27594783 | copper atom | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Copper results in increased expression of CENPQ mRNA | CTD | PMID:17205981 | copper(0) | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Copper results in increased expression of CENPQ mRNA | CTD | PMID:17205981 | coumestrol | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Coumestrol results in increased expression of CENPQ mRNA | CTD | PMID:19167446 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of CENPQ mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CENPQ mRNA | CTD | PMID:20106945 and PMID:25562108 | dibutyl phthalate | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CENPQ mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CENPQ mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPQ mRNA | CTD | PMID:27188386 | Enterolactone | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of CENPQ mRNA | CTD | PMID:23649840 | folic acid | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CENPQ mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CENPQ mRNA | CTD | PMID:23649840 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CENPQ mRNA | CTD | PMID:25539665 | kojic acid | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | kojic acid results in decreased expression of CENPQ mRNA | CTD | PMID:16595896 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of CENPQ mRNA | CTD | PMID:28341135 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of CENPQ mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CENPQ mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CENPQ mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of CENPQ mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Cenpq (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CENPQ mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CENPQ mRNA | CTD | PMID:34911549 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CENPQ mRNA | CTD | PMID:27153767 | phenobarbital | affects expression | ISO | Cenpq (Mus musculus) | 6480464 | Phenobarbital affects the expression of CENPQ mRNA | CTD | PMID:23091169 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of CENPQ mRNA | CTD | PMID:30047161 | progesterone | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Progesterone results in increased expression of CENPQ mRNA | CTD | PMID:18070364 | resveratrol | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CENPQ mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPQ mRNA | CTD | PMID:27188386 | senecionine | increases expression | EXP | | 6480464 | senecionine results in increased expression of CENPQ mRNA | CTD | PMID:32419051 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of CENPQ mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CENPQ mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CENPQ mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CENPQ mRNA | CTD | PMID:21592394 | tetrachloromethane | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CENPQ mRNA | CTD | PMID:27339419 and PMID:31919559 | thimerosal | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Thimerosal results in increased expression of CENPQ mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CENPQ mRNA | CTD | PMID:22659510 and PMID:23411599 | titanium dioxide | increases expression | ISO | Cenpq (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CENPQ mRNA | CTD | PMID:23557971 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of CENPQ mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CENPQ mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CENPQ mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | CENPQ (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPQ mRNA | CTD | PMID:27188386 | trovafloxacin | decreases expression | ISO | Cenpq (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CENPQ mRNA | CTD | PMID:35537566 | valproic acid | decreases methylation | ISO | CENPQ (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CENPQ gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | CENPQ (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CENPQ mRNA | CTD | PMID:23179753 and PMID:27188386 | vorinostat | increases expression | ISO | CENPQ (Homo sapiens) | 6480464 | vorinostat results in increased expression of CENPQ mRNA | CTD | PMID:27188386 | |